Anne A. Finucane is Director at CVS HEALTH Corp (CVS). They have made 2 open-market trades across 1 company since 2012, most recently 2026-10-16.
CIK 0001511491
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| WSM | SELL · 10b5-1 | 2026-10-16 | 2026-10-16 | $252.14 | $200K | — | — | — |
| CVS | SELL | 2025-08-20 | 2025-08-29 | $71.02 | $533K | +2.3% | +3.5% | +10.1% |
| CVS | SELL | 2016-01-04 | 2016-01-05 | $95.87 | $192K | -1.7% | -0.9% | +9.4% |
| CVS | SELL · 10b5-1 | 2013-04-15 | 2013-04-16 | $57.24 | $29K | -2.1% | +0.3% | +0.3% |
| CVS | SELL · 10b5-1 | 2012-09-17 | 2012-09-18 | $46.87 | $47K | -2.1% | +0.3% | +0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.